The latest -Anti-Infective Drugs Markets -Report By Aarkstore

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) January 23, 2012 -- Anti-Infective Drugs Markets

http://www.emarketreports.com/reports/Anti-Infective-Drugs-Markets-66396.html



Anti-Infective Drugs Markets

Six infectious diseases--pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS--account for half of all premature deaths worldwide, killing mostly children and young adults, according to the World Health Organization (WHO). Moreover, threatening pandemics such as swine flu (H1N1 influenza A virus) are adding significant pressure to already strained healthcare budgets of governments around the world. This report TriMark Publications analyzes the anti-infective drugs market and highlights the existing and developing anti-infectives used to ameliorate infectious diseases' afflictions on humankind. Anti-infective drugs include: anti-viral therapeutics, antibiotics, anti-fungal agents and prophylactic treatments such as vaccines. Particular attention is paid to the clinical market segment and the pharmaceutical/biotechnology companies involved in anti-infective drugs with specific emphasis on each company's sales focus, product portfolio and R&D pipeline. To date, the most successful anti-infective drugs target the human immunodeficiency virus (HIV, the virus that causes AIDS), the herpes virus (HSV-1 and HSV-2), bacterial infections and hepatitis C (HCV). A number of exciting novel anti-viral and antibiotic compounds are currently revolutionizing anti-infective drugs markets, including Truvada and Valtrex, which are anti-HIV and anti-herpes therapies, respectively. Significant resources are also being dedicated toward hepatitis A (HAV), hepatitis B (HBV) and Staph infections, including MRSA. What's more, this study will examine the existing and developing anti-infective drugs targeted at infectious diseases that continue to devastate developing countries, including: cholera, dengue fever, meningitis, rotavirus, typhoid and yellow fever.



Table of Contents :



1. Overview 9

1.1 Statement of Report 9

1.2 Scope of the Report 9

1.3 Methodology 10

1.4 Executive Summary 11



2. Clinical Syndromes and Therapy 20

2.1 Head and Neck 22

2.1.1 Sinusitis 22

2.1.2 Pharyngotonsillitis 23

2.1.3 Deep Neck Infections 23

2.1.4 Otitis Media and Externa 23

2.1.5 Acute Suppurative Thyroiditis 23

2.2 Eye 24

2.2.1 Conjunctivitis 24

2.2.2 Keratitis 24

2.2.3 Iritis 24

2.2.4 Retinitis 25

2.2.5 Endophthalmitis 25

2.3 Skin and Lymph Nodes 25







INDEX OF FIGURES



Figure 1.1: Leading Causes of Death in the U.S., 1961-2007 12

Figure 1.2: Global Distribution of Anti-Infective Drug Sales by Geography 15

Figure 2.1: Incidence Rates of Invasive MRSA Infections by Age 20

Figure 2.2: U.S. Child Death Rate from Preventable Diseases, 2007 22

Figure 2.3: Infection Rate of Serotype 19A by Age Group in the U.S., 1998-2006 27

Figure 2.4: U.S. Hospitalizations for Types of Respiratory Diseases in Children Under 15 Years of Age 27

Figure 2.5: Economic Burden of Select Lung Diseases in the U.S., 2007 28



INDEX OF TABLES



Table 1.1: Top Ten Causes of Death Worldwide 12

Table 1.2: Leading Pharmaceutical Companies in the Anti-Infective Market, 2009 16

Table 2.1: Annual Rates of Global Infectious Diseases 21

Table 2.2: Drugs in Development for Chronic Hepatitis B, 2010 40

Table 2.3: Global HIV Statistics, 2008 50

Table 3.1: Top-Selling Anti-Infective Drugs, 2008 59

Table 3.2: Sales for Leading Companies' Infectious Diseases Segments, 2008 60



For Related reports Plz Follow the Link:



http://www.aarkstore.com/search/viewresults.asp?search=Drugs &PubId=&pagenum=1

anti-infectives     antiretroviral     infectious diseases